NovoCure (NVCR) Interest & Investment Income (2021 - 2026)

NovoCure has disclosed Interest & Investment Income across 6 years of filings, most recently posting -$1.9 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 141.61% year-over-year to -$1.9 million; the TTM figure through Jun 2026 stood at $1.7 million (down 95.97% YoY), while the FY2025 annual figure was $17.6 million, down 65.59% from the prior year.
• Interest & Investment Income came in at -$1.9 million for Q2 2026 at NovoCure, down from -$1.8 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $19.8 million in Q4 2024 to a low of -$1.9 million in Q2 2026.
• Average Interest & Investment Income over 5 years is $8.2 million, with a median of $9.0 million recorded in 2023.
• Year-over-year, Interest & Investment Income jumped 952.09% in 2022 and sank 141.61% in 2026.
• Over 5 years, Interest & Investment Income stood at $18.5 million in 2022, then dropped by 2.4% to $18.1 million in 2023, then advanced by 9.25% to $19.8 million in 2024, then slumped by 102.84% to -$561000.0 in 2025, then slumped by 236.9% to -$1.9 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were -$1.9 million in Q2 2026, -$1.8 million in Q1 2026, and -$561000.0 in Q4 2025.